<?xml version="1.0" encoding="UTF-8"?>
<STUDY_SET xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <STUDY center_name="GEO" alias="GSE188640" accession="SRP345659">
    <IDENTIFIERS>
      <PRIMARY_ID>SRP345659</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioProject" label="primary">PRJNA779738</EXTERNAL_ID>
      <EXTERNAL_ID namespace="GEO">GSE188640</EXTERNAL_ID>
    </IDENTIFIERS>
    <DESCRIPTOR>
      <STUDY_TITLE>Blocking immunosuppressive neutrophils deters pY696-EZH2-driven brain metastases</STUDY_TITLE>
      <STUDY_TYPE existing_study_type="Other"/>
      <STUDY_ABSTRACT>In brain metastatic cells, enhancer of zeste homologue 2 (EZH2) is highly expressed and phosphorylated at tyrosine-696 (pY696-EZH2) by nuclear-localized Src tyrosine kinase. Phosphorylation of EZH2 at Y696 changes its binding preference from histone H3 to RNA polymerase II, which consequently switches EZH2's function from a methyltransferase to a transcription factor that increases c-Jun expression. c-Jun upregulates pro-tumorigenic inflammatory cytokines, including granulocyte-colony stimulating factor (G-CSF), which recruits Arg1-positive and PD-L1-positive immunosuppressive neutrophils into the brain to drive metastasis outgrowth. Overall design: We examined Pol II binding in samples with differential EZH2 activity (wild-type EZH2, EZH2 knockout, and re-expression of mutant EZH2) using ChIPseq.</STUDY_ABSTRACT>
      <CENTER_PROJECT_NAME>GSE188640</CENTER_PROJECT_NAME>
    </DESCRIPTOR>
    <STUDY_LINKS>
      <STUDY_LINK>
        <XREF_LINK>
          <DB>pubmed</DB>
          <ID>32461334</ID>
        </XREF_LINK>
      </STUDY_LINK>
    </STUDY_LINKS>
  </STUDY>
</STUDY_SET>
